1/32
Vocabulary flashcards covering humoral immune responses, effector mechanisms, complement regulatory proteins, and immunoglobulin attributes based on the Chapter 7 and 8 review booklet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
T-dependent antigens
Antibody responses to protein antigens that require antigen-specific CD4+ T cell help and display of the antigen on the B cell surface via MHC CII; this leads to B cell proliferation, isotype switching, high-affinity antibodies, and memory cell formation.
T-independent antigens
Antibody responses to nonprotein antigens (polysaccharides, lipids, nucleic acids) that do not require helper T cells; activation is provided by recognition of common microbial constituents or extensive cross-linking of BCRs.
Antibody-dependent cellular cytotoxicity (ADCC)
Process where CD16 (Fc receptor) on NK cells recognizes antibody-coated target cells leading to their killing; also involves IgE coating helminths for eosinophils to bind via their IgE Fc receptor.
Complement
A collection of plasma proteins activated by microbes or antibodies; all three pathways (Alternative, Lectin, Classical) lead to the generation of C3b, which is deposited on microbes and degraded to C3d for binding to CR2/CD21.
Opsonization
The coating of microbes with C3b or antibodies to promote phagocytosis and destruction; C3b is recognized by CR1/CD35 expressed on phagocytes.
Neutralization
Antibodies blocking the entry of microbes into the host at epithelial surfaces, preventing the binding of microbes to neighboring cells, and inhibiting the binding of toxins to cells.
FcRn
Neonatal Fc receptor expressed in the placenta for maternal IgG transfer and on endothelial cells to protect IgG from catabolism, thereby prolonging its half-life in the blood.
Poly-IgR
A receptor on the basal surface of epithelial cells that binds IgA and IgM to transport them to the luminal surface; it is cleaved to release IgA as a secretory piece.
FcγRIIB (CD32)
A low-affinity receptor that negatively regulates B cells, DCs, and mast cells by adjusting the activation threshold and providing feedback inhibition of B cells.
FcϵRI
A high-affinity receptor for IgE expressed on mast cells, basophils, and eosinophils; its activation leads to degranulation and the secretion of lipid inflammatory mediators.
FcγRIII (CD16)
A low-affinity receptor for Ig expressed on NK cells that mediates antibody-dependent cellular cytotoxicity (ADCC).
FcγRI (CD64)
A high-affinity receptor for Ig gamma heavy chains expressed on macrophages and neutrophils that enables the ingestion and degradation of bacteria bound by IgG1 and IgG3.
CD23
Also known as FceRIIB; a low-affinity IgE Fc receptor that promotes the attachment of eosinophils to worms, leading to ADCC.
C3a
A protein produced by proteolysis of C3 that is chemotactic for neutrophils and stimulates the release of inflammatory mediators and leukocyte movement into tissues.
Live-attenuated vaccine
Vaccines consisting of viruses selected for lack of pathogenicity while retaining infectivity; they stimulate neutralizing antibodies to protect against subsequent infection.
Conjugate vaccine
A vaccine where a capsular polysaccharide is coupled with a highly immunogenic protein to allow B cells to recruit helper T cell recognition of different epitopes.
Subunit vaccine
Vaccines composed of microbial proteins or polysaccharides, such as inactivated toxins, which stimulate antibodies to neutralize native toxins and microbes.
Follicular B cells
B cells that reside in lymphoid follicles and primarily contribute to T-dependent, class-switched, and high-affinity antibody responses to protein antigens.
Marginal-zone B cells
B cells that play a greater role specifically in T-independent immune responses.
B cell co-receptor complex
A signaling complex consisting of CD19, CD21 (which binds to C3d), and CD81.
C1q INH
A serine protease inhibitor that prevents the assembly of the C1 complex (C1q, C1r, C1s), blocking the classical pathway of complement activation.
Factor I
A plasma protein that proteolytically cleaves C3b and C4b into inactive fragments with the help of cofactors like MCP and Factor H.
Factor H
A cofactor for Factor I-mediated cleavage of C3b and C4b that causes the dissociation of alternative pathway C3 convertase subunits.
Decay accelerating factor (DAF)
CD55; a membrane protein that interferes with the formation of C3 convertase by blocking the binding of Bb to C3b or C4b to C2a.
CD59
A membrane protein that blocks C9 binding, thereby preventing the formation of the Membrane Attack Complex (MAC).
Primary Immune Response (Lag)
The interval after immunization before peak response, usually lasting ∼5−10 days, characterized predominantly by IgM over IgG.
Secondary Immune Response (Lag)
The interval after immunization before peak response, usually lasting ∼1−3 days, characterized by higher average affinity and a relative increase in IgG.
Follicular DC
Cells in the germinal center that display antigens using Fc receptors or C3 receptors (binding C3b and C3d) to immune complexes.
IgM
Comprises ∼13% of serum antibodies; exists as a monomer on B cells and a pentamer when secreted; functions in complement activation and apoptosis of self-reactive cells.
IgG
Comprises ∼80% of serum antibodies; monomeric form that mediates neonatal immunity, Fc receptor-dependent phagocytosis, ADCC, and feedback inhibition of B cells.
IgE
Comprises <1% of serum antibodies; functions in mast cell degranulation (immediate hypersensitivity) and defense against helminths.
IgA
Comprises ∼6% of serum antibodies; monomeric in serum and dimeric when secreted; critical for mucosal immunity in the GI and respiratory tracts.
IgD
Comprises ∼0.2% of serum antibodies; functions by binding to basophils and mast cells.